Global overview of health systems oversight and financing for kidney care

      Reliable governance and health financing are critical to the abilities of health systems in different countries to sustainably meet the health needs of their peoples, including those with kidney disease. A comprehensive understanding of existing systems and infrastructure is therefore necessary to globally identify gaps in kidney care and prioritize areas for improvement. This multinational, cross-sectional survey, conducted by the ISN as part of the Global Kidney Health Atlas, examined the oversight, financing, and perceived quality of infrastructure for kidney care across the world. Overall, 125 countries, comprising 93% of the world’s population, responded to the entire survey, with 122 countries responding to questions pertaining to this domain. National oversight of kidney care was most common in high-income countries while individual hospital oversight was most common in low-income countries. Parts of Africa and the Middle East appeared to have no organized oversight system. The proportion of countries in which health care system coverage for people with kidney disease was publicly funded and free varied for AKI (56%), nondialysis chronic kidney disease (40%), dialysis (63%), and kidney transplantation (57%), but was much less common in lower income countries, particularly Africa and Southeast Asia, which relied more heavily on private funding with out-of-pocket expenses for patients. Early detection and management of kidney disease were least likely to be covered by funding models. The perceived quality of health infrastructure supporting AKI and chronic kidney disease care was rated poor to extremely poor in none of the high-income countries but was rated poor to extremely poor in over 40% of low-income countries, particularly Africa. This study demonstrated significant gaps in oversight, funding, and infrastructure supporting health services caring for patients with kidney disease, especially in low- and middle-income countries.

      Keywords

      To read this article in full you will need to make a payment
      ISN Member Login
      ISN Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • World Health Organization
        Health Systems Financing: Toolkit on Monitoring Health Systems Strengthening.
        World Health Organization, Geneva, Switzerland2008
        • Organisation for Economic Co-operation and Development
        Focus on Health Spending: OECD Health Statistics.
        Organisation for Economic Co-operation and Development, Paris, France2015
        • World Health Organization
        WHO Global Health Expenditure Atlas.
        World Health Organization, Geneva, Switzerland2014
        • World Health Organization
        World Health Statistics 2014: Indicator Compendium.
        World Health Organization, Geneva, Switzerland2014
        • Couser W.G.
        • Remuzzi G.
        • Mendis S.
        • Tonelli M.
        The contribution of chronic kidney disease to the global burden of major noncommunicable diseases.
        Kidney Int. 2011; 80: 1258-1270
        • World Health Organization
        Health in 2015: From MDGs, Millennium Development Goals to SDGs, Sustainable Development Goals.
        World Health Organization, Geneva, Switzerland2015
      1. International Society of Nephrology. ISN regions. 2017. Available at: https://www.theisn.org/about-isn/regions. Accessed August 23, 2017.

      2. World Bank. World Bank country and lending groups: World Bank data help desk. Available at: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups. Accessed August 23, 2017.

        • Boerma T.
        • Eozenou P.
        • Evans D.
        • et al.
        Monitoring progress towards universal health coverage at country and global levels.
        PLoS Med. 2014; 11e1001731
        • Barsoum R.S.
        Haemodialysis: cost-conscious end-stage renal failure management.
        Nephrology. 1998; 4: S96-S100
      3. International Health Partnership. Progress in the International Health Partnership and Related Initiatives, 2014 Performance Report. Geneva, Switzerland: International Health Partnership; 2014.

        • Gabr M.
        Organ transplantation in developing countries.
        World Health Forum. 1998; 19: 120-123
        • World Health Organization
        Monitoring the Building Blocks of Health Systems: A Handbook of Indicators and Their Measurement Strategies.
        World Health Organization, Geneva, Switzerland2010
        • Sakhuja V.
        • Sud K.
        End-stage renal disease in India and Pakistan: burden of disease and management issues.
        Kidney Int Suppl. 2003; 83: S115-S118
        • Moosa M.R.
        • Kidd M.
        The dangers of rationing dialysis treatment: the dilemma facing a developing country.
        Kidney Int. 2006; 70: 1107-1114
        • Liyanage T.
        • Ninomiya T.
        • Jha V.
        • et al.
        Worldwide access to treatment for end-stage kidney disease: a systematic review.
        Lancet. 2015; 385: 1975-1982
        • Barsoum R.S.
        • Khalil S.S.
        • Arogundade F.A.
        Fifty years of dialysis in Africa: challenges and progress.
        Am J Kidney Dis. 2015; 65: 502-512
        • Inker L.A.
        • Astor B.C.
        • Fox C.H.
        • et al.
        KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.
        Am J Kidney Dis. 2014; 63: 713-735
        • Komenda P.
        • Ferguson T.W.
        • Macdonald K.
        • et al.
        Cost-effectiveness of primary screening for CKD: a systematic review.
        Am J Kidney Dis. 2014; 63: 789-797
        • Kondo M.
        • Yamagata K.
        • Hoshi S.L.
        • et al.
        Cost-effectiveness of chronic kidney disease mass screening test in Japan.
        Clin Exp Nephrol. 2012; 16: 279-291
        • Farmer A.J.
        • Stevens R.
        • Hirst J.
        • et al.
        Optimal strategies for identifying kidney disease in diabetes: properties of screening tests, progression of renal dysfunction and impact of treatment—systematic review and modelling of progression and cost-effectiveness.
        Health Technol Assess. 2014; 18: 1-128
        • Kondo M.
        • Yamagata K.
        • Hoshi S.L.
        • et al.
        Budget impact analysis of chronic kidney disease mass screening test in Japan.
        Clin Exp Nephrol. 2014; 18: 885-891
        • Manns B.
        • Hemmelgarn B.
        • Tonelli M.
        • et al.
        Population based screening for chronic kidney disease: cost effectiveness study.
        BMJ. 2010; 341: c5869
        • Johnson D.W.
        • Atai E.
        • Chan M.
        • et al.
        KHA-CARI guideline: early chronic kidney disease: detection, prevention and management.
        Nephrology. 2013; 18: 340-350
        • Levey A.S.
        • Atkins R.
        • Coresh J.
        • et al.
        Chronic kidney disease as a global public health problem: approaches and initiatives—a position statement from Kidney Disease Improving Global Outcomes.
        Kidney Int. 2007; 72: 247-259
      4. Powles J, Comim F. Public health infrastructure and knowledge. In: Smith R, Beaglehole R, Woodward D, Drager N, eds. Global Public Goods for Health: Health Economic and Public Health Perspectives. 2003:159–176.

        • US Department of Health and Human Services
        National Healthcare Disparities Report.
        US Department of Health and Human Services, Bethesda, MD2010
        • Marmot M.
        • Friel S.
        • Bell R.
        • et al.
        Closing the gap in a generation: health equity through action on the social determinants of health.
        Lancet. 2008; 372: 1661-1669
      5. Provincial Health Services Authority. Towards Reducing Health Inequities: A Health System Approach to Chronic Disease Prevention. A Discussion Paper. British Columbia, Canada: Provincial Health Services Authority; Ottawa: Government of Canada; 2011.

        • Bello A.K.
        • Johnson D.W.
        • Feehally J.
        • et al.
        Global Kidney Health Atlas (GKHA): design and methods.
        Kidney Int Suppl. 2017; 7: 145-153https://doi.org/10.1016/j.kisu.2017.08.001
        • Bello A.K.
        • Levin A.
        • Tonelli M.
        • et al.
        Assessment of global kidney health care status.
        JAMA. 2017; 317: 1864-1881
      6. Blanchette C, Tolley E. Public and Private Sector Involvement in Health Care Systems: An International Comparison. Revised edition. Ottawa: Government of Canada; 2001.

        • Organisation for Economic Co-operation and Development
        Public- and Private-Sector Involvement in Health-Care Systems: A Comparison of OECD Countries.
        Revised edition. Organisation for Economic Co-operation and Development, Paris, France2001